期刊文献+

丙戊酸钠诱导髓系白血病细胞分化相关的分子标志物研究 被引量:1

Molecular marker associated with valproate induced differentiation in myeloid leukemia cells
原文传递
导出
摘要 目的:研究组蛋白去乙酰化酶(HDAC)抑制剂丙戊酸钠(VPA)诱导髓系白血病细胞分化相关的分子标志物。方法:采用流式细胞术检测细胞表面分化抗原的表达,采用实时定量PCR和蛋白印迹法检测细胞周期相关蛋白、凋亡相关蛋白、活性氧簇(ROS)相关蛋白及组蛋白甲基化调控蛋白的表达。结果:VPA较低剂量(1 mmol/L)即诱导HL-60细胞分化,K562细胞对VPA诱导分化不敏感。VPA诱导细胞分化作用与组蛋白乙酰化基础水平及药物处理后调变间无显著相关性,VPA诱导分化与细胞周期相关蛋白、凋亡相关蛋白、ROS相关调控蛋白的表达无影响。VPA诱导分化效应与细胞不同HDAC表达水平相关,K562细胞高表达HDAC6,对VPA诱导分化不敏感,且经VPA处理后细胞组蛋白K9甲基化水平较HL-60细胞明显提高。结论:VPA诱导白血病细胞分化的作用可能与细胞HDAC6的低水平表达及组蛋白K9甲基化水平调控有关,而与组蛋白乙酰化基础水平及细胞周期相关蛋白、ROS相关调控蛋白等无关。 Objective To investigate the molecular marker associated with valproate(VPA),a histone deacetylase(HDAC) inhibitor,induced differentiation in myeloid cells.Methods Expression of cell surface differentiation antigen was analyzed by flow cytometry,and real-time quantitative PCR and Western blot were used to detect cell cycle,apoptosis,ROS related proteins and histone methylation regulatory protein.Results VPA at low concentration(1 mmol/L)can induce differentiation in HL-60 cells,while K562 cells were not sensitive to VPA induced differentiation.No significant relevance was detected between VPA induced differentiation and histone acetylation level before and after the treatment.The expressions of cell cycle,apoptosis and ROS related proteins were similar in both HL-60 and K562 cells.Expression of HDAC was different in HL60 and K562 cells.The expression of HDAC6 was significantly higher in K562 cells than in HL-60 cells.Upregulation of histone K9 methylation was significantly higher in K562 than in HL-60 cells after treatment with VPA.Conclusions VPA can induce differentiation in HL-60 cells,which might be associated with the low level of HDAC6 and modulation of histone K9 methylation,but not the level of acetylated histone protein and expressions of cell cycle,apoptosis and ROS related proteins.
出处 《诊断学理论与实践》 2011年第5期434-439,共6页 Journal of Diagnostics Concepts & Practice
基金 上海市优秀青年医师 上海市领军人才后备队计划
关键词 急性髓细胞白血病 丙戊酸钠 组蛋白去乙酰化酶 机制 Acute myeloid leukemia Valproate Histone deacetylase Mechanism
  • 相关文献

参考文献22

  • 1Konstanze D, Hartmut D. Molecular characterization of acute myeloid leukemia [J]. Haematol,2008,93 (7):976- 982.
  • 2Zhu P, Huber E, Kiefer F, et al. Specific and redundant functions of histone deacetylases in regulation of cell cy- cle and aooptosis[J]. Cell Cvcle,2004,3(lO):1240-1242.
  • 3Schlenk RF, Dfihner K, Krauter J, et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia[J]. N Engl J Med,2008,358(18):1909- 1918.
  • 4Odenike OM, Alkan S, Sher D, et al. Histone deacetylase inhibitor romidepsin has differential activity in core bin- ding factor acute myeloid leukemia [J]. Clin Cancer Res, 2008,14(21 ):7095 -7101.
  • 5Kuendgen A, Gattermann N. Valproic acid for the treat- ment of myeloid malignancies [J]. Cancer,2007,110 (5): 943-954.
  • 6G~ittlicher M, Minucci S, Zhu P, et al. Valproic acid de- fines a novel class of HDAC inhibitors inducing differen- tiation of transformed cells [J]. EMBO J,2001,20 (24) 6969-6978.
  • 7Xu W, Ngo L, Perez G, et al. Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell re- sponse to histone deacetylase inhibitor[J]. Proc Nail Acad Sei U S A,2006,103(42):15540-15545.
  • 8Tan J, Cang S, Ma Y, et al. Novel histone deacetylase in- hibitors in clinical trials as anti-cancer agents [J]. J Hematol 0ncol,2010,3:5.
  • 9Gurvich N, Tsygankova OM, Meinkoth JL, et al. Histonedeacetylase is a target of valproic acid-mediated cellular differentiation[J]. Cancer Res,2004,64:1079-1086.
  • 10Cimino G, Lo-Coco F, Fenu S, et al. Sequential valproic acid/all-trans retinoic acid treatment reprograms differen- tiation in refractory and high-risk acute myeloid leukemia [J]. Cancer Res,2006,66(17):8903-8911.

二级参考文献11

  • 1Phiel CJ,Zhang F,Huang EY,et al.Histone deacetylase is a direct target of valproic acid,a potent anticonvulsant,mood stabilizer,and teratogen.J Biol Chem,2001,276:36734-36741.
  • 2Kuendgen A,Strupp C,Aivado M,et al.Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.Blood,2004,104:1266-1269.
  • 3Raffoux E,Chaibi P,Dombret H,et al.Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia.Haematologica,2005,90:986-988.
  • 4Witt O,Sand K,Pekrun A.Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways.Blood,2000,95:2391-2396.
  • 5Hutt-Taylor SR,Harnish D,Richardson M,et al.Sodium butyrate and a T lymphocyte cell line-derived differentiation factor induce basophilic differentiation of the human promyelocytic leukemia cell line HL-60.Blood,1988,71:209-215.
  • 6Ruefli AA,Ausserlechner MJ,Bernhard D,et al.The histone deacetylase inbibitor and chemotherapeutic agent suberoylanilide hydroxamic acid(SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species.Proc Natl Ac ad Sci U S A,2001,98:10833-10838.
  • 7Bernhard D,Skvortsov S,Tinhofer I,et al.Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.Cell Death Differ,2001,8:1014-1021.
  • 8Kawagoe R,Kawagoe H,Sano K.Valproic acid induces apoptosis in human leukemia cells by stimulating both caspasedependent and-independent apoptotic signaling pathways.Leuk Res,2002,26:495-502.
  • 9Turner BM,O'Neill LP.Histone acetylation in chromatin and chromosomes.Semin Cell Biol,1995,6:229-236.
  • 10Kuo MH,Brownell JE,Sobel RE,et al.Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines.Nature,1996,383:269-272.

共引文献2

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部